KeViRx, Inc.
PrivateLast Round
Accelerator
Aug 28, 2024
Total Funding Raised
$3.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
KeViRx, Inc. operates in Healthcare & Life Sciences and is based in Charlottesville, Virginia. Its latest recorded funding round was an Accelerator round in August 2024.
KeViRx, Inc. is a biotechnology company that develops small molecule drugs to treat microvascular leakage and inflammation for diseases such as acute lung injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KeViRx, Inc. Comparables
Compare KeViRx, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vasomune Therapeutics | 88% | |
| CMTx Biotech, Inc. | 79% | |
| Aqualung Therapeutics Corporation | 78% |
For institutional investors. Book with your work email.
KeViRx, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 28, 2024 | ||||
| Grant | Jun 11, 2024 | ||||
| Grant | Aug 29, 2022 | ||||
| Accelerator | Feb 18, 2022 | ||||
| Grant | Oct 5, 2021 | ||||
Grant | Jun 15, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
KeViRx, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Activation Capital | Accelerator |
| gener8tor | Accelerator |
| NIH RADx | Grant |
| U.S. Department of Defense | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| Virginia Innovation Partnership Corporation | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 266% MoM, reaching 2K.
- Jun 11, 2024
Secured $2M from the U.S. Department of Defense and Department of War.
For institutional investors. Book with your work email.
KeViRx, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about KeViRx, Inc.'s valuation, stock price, and market status.
Is KeViRx, Inc. a public or private company?
KeViRx, Inc. is a private company.
What is the current stock price of KeViRx, Inc.?
KeViRx, Inc. is a private company, so its shares have no public market price. Caplight tracks KeViRx, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is KeViRx, Inc. worth (valuation)?
Valuation information for KeViRx, Inc. is not publicly available.
Can I buy KeViRx, Inc. stock?
KeViRx, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was KeViRx, Inc.'s last funding round?
KeViRx, Inc.'s most recent funding round was Accelerator on August 28, 2024.
Who are the main investors in KeViRx, Inc.?
Key investors in KeViRx, Inc. include National Cancer Institute, Activation Capital, gener8tor, NIH RADx, U.S. Department of Defense.
Will KeViRx, Inc. IPO soon?
No public IPO plans have been announced for KeViRx, Inc..
How can I track KeViRx, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in KeViRx, Inc.'s shares on secondary markets.